Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2026 May 4;20(5):e0013662. doi: 10.1371/journal.pntd.0013662

Modelling approaches for predicting the distribution of skin NTDs: A systematic review

Mesoud A Bushara 1,*, Rowa Hassan 2, Rana Ahmed 1,3, Jorge Cano 4, Gail Davey 2, Eltayeb Ganawa 1, Hope Simpson 2,5
Editor: Paul O Mireji6
PMCID: PMC13155686  PMID: 42081581

Abstract

Background

Skin neglected tropical diseases (NTDs) such as cutaneous leishmaniasis, lymphatic filariasis, mycetoma, and podoconiosis affect millions in endemic regions, but are under-recorded despite causing significant burdens. Predictive modelling has been used to estimate the distribution and prevalence of some of these diseases, and predictions may be useful for identifying at-risk populations and guiding interventions. This review synthesises the literature on modelling approaches to predict skin NTD distributions, aiming to identify prevalent methodologies, evaluate their strengths and limitations, highlight research gaps, and provide recommendations for enhancing their utility.

Methods

We conducted a systematic literature review from three databases and included studies published from 2000-2024. Studies were included if they employed statistical models or machine learning algorithms to predict the distribution of skin NTDs. Two independent reviewers screened titles, abstracts, and full texts. Data extracted included disease, study region, source of epidemiological data, model types and predictors.

Results

From 2,870 retrieved records, 68 met the inclusion criteria. The most modelled skin NTDs were cutaneous leishmaniasis (n = 26) and lymphatic filariasis (n = 18). Geostatistical modelling was the most common approach, followed by ecological niche modelling, with MaxEnt and generalised linear models constituting the predominant model types. Common environmental covariates included climate, land cover and land use, elevation, and soil data. The types of epidemiological data varied, with many studies relying on passive surveillance and pseudoabsence data. The risk of bias was high among ecological niche models.

Conclusions

Environmental and geostatistical models can inform targeted interventions for skin NTDs, aiding efficient resource allocation and public health planning. However, data limitations, especially the absence of true absence data, underreporting and variations in surveillance sensitivity, can reduce model accuracy and undermine decision-makers’ confidence. Future studies should focus on incorporating information about case identification into modelling frameworks, including a broader spectrum of environmental and socio-economic determinants, and ensuring validation across diverse geographic regions.

Author summary

Skin diseases caused by neglected tropical diseases (NTDs) such as cutaneous leishmaniasis, lymphatic filariasis, mycetoma, and podoconiosis affect millions of people, mostly in poorer regions. These conditions can cause disability, stigma, and poor mental health, yet they are often underreported and not well mapped. Predictive modelling, which combines health and environmental data, can help show where these diseases are likely to occur and guide public health responses. In this study, we reviewed published research that used modelling to predict the distribution of skin NTDs. We found that most studies focused on a few diseases and used statistical or environmental models. While useful, these models often struggled with limited or incomplete data. Our review highlights the need for better surveillance and improved data to make models more accurate. Stronger models can help health programs direct resources more efficiently and support efforts to control and eventually eliminate these diseases.

Introduction

Skin neglected tropical diseases (NTDs) are a group of conditions that fundamentally affect the skin, cause significant morbidity, and can lead to disabilities, stigmatization, and negative mental health outcomes [1]. The skin NTDs recognized by the World Health Organization (WHO) are Buruli ulcer (BU), cutaneous leishmaniasis (CL), Hansens disease (leprosy), lymphatic filariasis (LF), mycetoma, chromoblastomycosis, and other deep mycoses, onchocerciasis (river blindness), post-kala-azar dermal leishmaniasis, scabies and other ectoparasitoses and yaws [2, 3]. Though the WHO does not include podoconiosis in this list, it recommends its integration with other skin NTDs for control and management. Dracunculiasis is another NTD affecting the skin but not included within the WHO strategic framework for skin NTD control [4].

Global frameworks for skin NTD control

The WHO has set targets for controlling and eliminating NTDs in a road map published in 2021, highlighting the importance of robust surveillance systems to track the prevalence and distribution of skin NTDs, along with strategies for mapping disease hotspots and planning interventions [3]. The WHO Skin NTD Framework promotes integrated management strategies, emphasizing surveillance, diagnosis, treatment, community engagement, and monitoring [2,5]. Effective targeting and integration of prevention, diagnosis, and treatment requires a thorough understanding of the geographical distributions of skin NTDs [6, 7].

Environmental determinants of Skin NTDs

NTDs exhibit significant variation in prevalence across different regions, influenced by factors such as climate, ecology, and socioeconomics [4, 8]. Those which are vector borne (CL, LF, onchocerciasis) have strong environmental determinants, limiting the distributions of the insects that carry them [9], as does podoconiosis, which only occurs in certain environments characterized by particular soil types, altitude, and precipitation conditions [1]. Others such as BU and mycetoma are transmitted from the environment and are known to be influenced by certain environmental factors, though evidence for this is more limited [10]. Leprosy, scabies and yaws are directly transmitted from person-to-person, and there is limited evidence for an effect of the environment on transmission, although scabies has been reported to be seasonal in some settings, while in others no meaningful seasonal influence has been observed [11, 12].

Existing data on Skin NTDs

For diseases like BU, leprosy, and scabies, data are often collected through passive surveillance. However, this approach has limitations resulting from poor healthcare access, low diagnostic capacity, and underreporting in endemic or high-prevalence areas, leading to underestimation of disease burdens [8, 13]. Moreover, there is a significant discrepancy in NTD cases recorded by programmes and reported to WHO [14]. Additionally, some affected countries lack the necessary surveillance systems to effectively track and document all cases, further contributing to the imprecision in global estimates of disease burdens. Active case detection is used for some skin NTDs, such as LF, through the Global Programme to Eliminate Lymphatic Filariasis (GPELF), with limited searches for BU and others [15]. Surveys for onchocerciasis (nodule prevalence) and podoconiosis (mainly for research) highlight the broader issue: high-quality survey data is scarce due to the high costs involved [16]. Consequently, current data often does not accurately represent the true distribution of skin NTDs, being influenced by varying levels of surveillance intensity across regions.

Predictive modelling approaches

In view of the gaps and biases affecting current data on skin NTDs, the last two decades have seen development of various models to predict the geographical distribution of certain skin NTDs at fine scales, providing estimates of prevalence or suitability for target diseases in regions with limited data [17]. The approaches used can be categorized broadly as ecological models, which link occurrence to environmental conditions, and geostatistical models, which model spatial dependency to predict prevalence between sampled locations, and can also incorporate environmental relationships [18].

Ecological models predict where organisms are likely to occur based on field observations and environmental factors. A variety of terms are used to describe overlapping approaches to this aim, including ecological niche modelling (ENM), species distribution modelling (SDM), and risk mapping. While the terms ENM and SDM are sometimes used interchangeably, there is growing recognition that they cover distinct, though related concepts [19]. According to this distinction, ENM predicts potential distributions based on fundamental niches, encompassing areas where a species/disease is found (the realised niche), and those with suitable habitat in which the target is non-existent (the unfilled niche), without distinguishing between these scenarios. In contrast, SDM is understood to predict actual distributions in geographic, rather than environmental space, based on both suitability and dispersion and colonisation potential [20, 21] or transmission models to generate risk maps which also account for the likelihood of contact and susceptibility [22]. However, risk mapping is also used to describe a variety of other approaches, which can include spatial effects. For the purposes of this review, we use the term “ecological models” to cover those which use statistical and/or machine learning approaches to relate occurrence of a target (meaning a disease or species) to environmental conditions, without incorporating spatial effects.

Since obtaining reliable data on disease or species non-occurrence is challenging, researchers often employ pseudoabsences or background points, representing locations where occurrence is unknown, but which are treated as model negatives. These enable comparison of environmental conditions at presence and background locations, allowing statistical relationships between occurrence and predictors to be fit and projected [23]. Ecological models do not typically quantify or account for spatial autocorrelation in occurrence records. Spatial autocorrelation, or spatial dependency, refers to the degree to which values of a particular measure (for instance suitability) are correlated with those at nearby locations. This effect can invalidate the assumptions of standard regression approaches and result in inaccuracies [24].

In contrast to ecological models, geostatistical models explicitly integrate and account for spatial dependency between nearby points, resulting in more precise and spatially consistent predictions [25]. These models have proven pivotal in charting the distribution of NTDs controlled by preventive chemotherapy (PC-NTDs) [26, 27], and have recently been applied to guide interventions against them [28, 29]. The application of geostatistical models to PC-NTDs reflects the availability of systematically collected survey data for these diseases, allowing prevalence to be modelled as a spatially continuous outcome. For diseases controlled mostly through individual based management, surveillance data tends to comprise reports of routinely identified cases. As a result, occurrence is represented by discrete points, and absence locations are not well defined [30].

The objective of this literature review is to describe, compare, and evaluate existing modelling approaches used to predict the distribution of skin NTDs. We aim to synthesize relevant studies to identify common modelling approaches, evaluate their strengths and limitations, and propose recommendations for improving skin-NTD prediction accuracy and utility.

Methodology

Search strategy

Our systematic search encompassed a combination of three databases: PubMed, Ovid, and Web of Science. The search strategy included a combination of terms and free-text keywords related to skin NTDs, prediction, and modelling, used the search string included in (Table 1). We restricted the search to studies published from 2000 onwards, as this period marks the expansion of spatial epidemiology and the widespread availability of geospatial tools, digital disease data, and environmental datasets. Earlier studies rarely employed modern predictive modelling approaches or accessible geospatial platforms, making them less comparable to contemporary methods. This restriction ensured methodological consistency and relevance to current public health applications.

Table 1. Example search string used for PubMed.

Component Search Terms Combine with
Diseases of interest (“Buruli ulcer”[Title/Abstract] OR “Bairnsdale ulcer”[Title/Abstract] OR “ulcerans”[Title/Abstract] OR “Leishman*”[Title/Abstract] OR leprosy[Title/Abstract] OR “mycobacterium lepr*”[Title/Abstract] OR Hansen[Title/Abstract] OR “lymphatic filariasis”[Title/Abstract] OR “brugia malayi”[Title/Abstract] OR “wuchereria bancrofti”[Title/Abstract] OR onchocerciasis[Title/Abstract] OR onchocerca*[Title/Abstract] OR “river blindness”[Title/Abstract] OR mycetoma[Title/Abstract] OR chromoblastomycosis[Title/Abstract] OR podoconiosis[Title/Abstract] OR scabies[Title/Abstract] OR yaws[Title/Abstract] OR treponem*[Title/Abstract] OR “guinea worm”[Title/Abstract] OR dracunc*[Title/Abstract] OR tungiasis*[Title/Abstract]) AND AND
Methods of interest ((“map”[Title/Abstract] OR “mapping”[Title/Abstract] OR “distribution”[Title/Abstract] OR “niche”[Title/Abstract] OR “suitability”[Title/Abstract] OR “geostatistic”[Title/Abstract] OR “ecolog*”[Title/Abstract])))
AND (model[Title/Abstract]))
AND
Publication Limits ((“2000/01/01”[Date - Publication]: “2025/09/30”[Date - Publication]))

The search was most recently updated in September 2024. Studies in English, French, Portuguese, Spanish, and Turkish were included, chosen for their relevance to endemic regions and the expertise of the review team. Non-English/French articles were translated using Google Translate. The auto-resolve feature in Rayyan [31] was used to remove duplicates. We also reviewed the references of key publications to identify relevant articles that may have been missed from the database search.

Eligibility criteria

Studies were included or excluded based on predefined criteria (Table 2). Eligible studies were those that used modelling approaches to predict the distribution of skin NTDs in humans at a fine-scale (pixel- or lowest administrative unit-level). The diseases of interest were BU, dracunculiasis (Guinea-worm disease), CL, Hansen’s disease (leprosy), LF, mycetoma, chromoblastomycosis, onchocerciasis (river blindness), podoconiosis, scabies, tungiasis, and yaws. We included studies that modelled either prevalence or suitability, using statistical models, machine learning algorithms, or geostatistics.

Table 2. Inclusion and Exclusion Criteria.

Category Inclusion criteria Exclusion criteria
Target Diseases Skin NTDs in humans: Buruli ulcer, dracunculiasis (Guinea-worm disease), cutaneous leishmaniasis, leprosy, lymphatic filariasis, mycetoma, chromoblastomycosis, onchocerciasis, podoconiosis, scabies, tungiasis, yaws. Disease not affecting the skin or not an NTD. Studies that predict distributions of skin NTD vectors or non-human reservoir only.
Data Source Use of epidemiological data from surveys, literature, active case searches, or routine surveillance. Simulated data
Modelling Focus Using spatial or ecological niche models to predict risk, suitability, occurrence, prevalence, or incidence in areas without observed data. Studies that do not predict the distribution of skin NTDs, for example: statistical/ epidemiological models without spatial component, time series with no spatial element.
Studies that analyse associations (e.g., spatial lag, Moran’s I) or smooth rates (e.g., Bayesian smoothing) without predicting into unobserved areas.
Spatial Scale Fine- resolution: pixel-level or the lowest administrative unit of a country. Larger administrative areas such as districts.
Publication characteristics Studies published in peer-reviewed journals or conference proceedings; published between 2000 and 2024 Not published in peer-reviewed journals or conference proceedings; published before 2000 or after 2024.

We excluded studies not in peer-reviewed journals, not in English, French, Portuguese, Turkish or Spanish, or published before 2000 or after 2024. We also excluded studies which used spatial analysis without predicting new areas and focusing on vectors and non-human hosts.

Study selection

All retrieved articles were uploaded to the Rayyan software, (S1 File). Two reviewers (MAB and RH) independently screened the titles and abstracts of each article to determine its relevance to the research topic. Full-text versions of articles which passed this initial screening were retrieved and independently evaluated by the same two reviewers. Any disagreements were resolved through discussion or, when necessary, by consulting a third reviewer (HS).

Data extraction process

Data were extracted independently by two reviewers using a bespoke Microsoft Excel spreadsheet containing the following fields: disease of interest, study region, country of lead author’s institutional affiliation, source of epidemiological data, model type(s), software used, environmental covariates, process to select predictors, sensitivity analysis, performance evaluation metrics, availability of model outputs, availability of model code, challenges and limitations of modelling approaches, and potential applications of model outputs. The source of epidemiological data was categorised as case notifications (defined as formal reports of disease detection from health facilities or laboratories to a central surveillance system), passive surveillance (defined as records of cases collected from health facilities), case search (defined as detection from a dedicated case finding activity for which the denominator population was not defined), surveys, and literature review (S2 File).

Risk of bias assessment

We conducted a structured risk of bias (RoB) assessment for all 68 included studies using a bespoke assessment tool incorporating elements from the Joanna Briggs Institute (JBI) checklist for cross sectional studies and a checklist for maximising reproducibility of ecological niche models [32]. Each study was evaluated across ten methodological domains, covering clarity of inclusion criteria, definition of study area and population, representativeness of participants, case definition, validity of exposure measurement, handling of environmental covariates, treatment of background or pseudoabsence data, and approaches to sampling bias, spatial autocorrelation, and statistical analysis. Based on these assessments, studies were categorized as low, moderate, or high risk of bias (S3 File).

Synthesis methods

Data were synthesised narratively, and key results were tabulated and visualised using plots produced in R (R version 4.1.1 (2021-08-10) [33].

Results

The literature search identified 1,756 studies relevant to the search terms. After duplicate removal, 818 articles were screened by title and abstract, narrowing the selection to 126 studies eligible for full-text review (Fig 1). Fifty-seven studies were excluded because they did not make spatial predictions (n = 39), did not use human cases (n = 15), did not make fine scale predictions (n = 1) or were not primary research studies (n = 1)). Ultimately, 68 studies met the inclusion criteria and were included in the final analysis.

Fig 1. Flow diagram illustrating the study selection process.

Fig 1

The following sections present the findings, focusing on the key themes that emerged from the reviewed literature. Key results are shown in Table 3.

Table 3. Summary of Results.

Data Extraction Category Frequencies
Total Studies Included 68
Diseases of Interest CL (26), LF (18), Onchocerciasis (7), Podoconiosis (7), Mycetoma (3),Tungiasis (3), BU (2), Leprosy (1), Dracunculiasis (1)
Study Countries Ethiopia (19), Nigeria (16), Kenya (14), Sudan (14), Côte d’Ivoire (14), Brazil (12), Sri Lanka (8)
Country of institutional affiliation of lead authors UK (16), USA (10), Ethiopia (7), Turkey (4), Australia (3), Colombia (2), Sudan (2), Switzerland (2), Brazil (2), Pakistan (2), Iran (2), Sweden (1), Sri Lanka (1), Hungary (1), Ghana (1), Zambia (1), Egypt (1), Mexico (1), France (1), Nigeria (1), Tunisia (1), Denmark (1), Indonesia (1), Palestine (1), Qatar (1), Argentina (1), Japan (1)
Modelling Approaches Geostatistical (35: GLMMs, IDW, Kriging).
Ecological (33: GLMs, Maxent, RF, etc.)
Source of Epidemiological Data used for modelling Survey (33), Passive (22), Notification (21), Literature (17), Case Search (3)
Inclusion of True absence (TA) or Pseudoabsence (PA) Data PA (35), PA & TA (5), TA only (20), None/NR (11)
Software Used R (39), GIS tools (32), MaxEnt, STATA/SPSS (4), WinBUGS/GeoBUGS (4)
Environmental Datasets Used for Modelling Precipitation (60), Temp (56), Elevation (60), Pop. Density (30), LULC (27), NDVI/LST (28), Water (28), Humidity (28), Soil (25)
Socioeconomic and development-related covariates Night-time light (20), Livestock (5), Healthcare access (2), Program indicators (2), Conflict indicator (1), food security indicator (1)
The Process of Selecting Predictors in the Study Literature(14), Correlation(16), Variable importance(12), Stepwise (AIC)(15), Expert judgment(11)
Sensitivity Analysis Parameter variation, Uncertainty quantification, Threshold sensitivity
Methods to Evaluate the Performance of Models AUC/ROC, Cross-validation, Fit stats, Residuals, External validation (17 studies)
Challenges & Limitations to effective modelling Data gaps, Generalizability, High computing cost, Code sharing, Sampling bias
Model Applications in Public Health Hotspot identification, MDA planning, Integration, Targeting Surveillance and interventions

Diseases of Interest

The studies examined a range of skin NTDs, with different transmission modes and types of disease agents (Fig 2). Vector-borne diseases, including CL, LF, and onchocerciasis, accounted for most studies (51 out of 68. The highest number of studies focused on CL (26 studies; records 1–26 in S2 File), followed by LF (18 studies; records 27–44 in (S2 File) and onchocerciasis (7 studies). Podoconiosis was the most commonly modelled among non-vector-borne conditions examined (7 studies; records 52–59 in Supplementary (S2 File), while mycetoma (bacterial or fungal origin) [34–36] and tungiasis were each studied in three cases [37–39]. Among bacterial diseases, BU appeared in two studies [40, 41], while lepros [42] was modelled in one [43]. One study modelled Dracunculiasis, caused by a parasite [44]. Notably, no studies were found for scabies, yaws, or chromoblastomycosis, presumably reflecting uncertainty about the type and strength of environmental drivers, and the multitude of causative organisms, in the case of chromoblastomycosis.

Fig 2. Number of Studies Identified by Disease and Transmission (Total = 68).

Fig 2

Study regions

The studies covered many regions, focusing on areas where skin NTDs are endemic, including Africa, Asia, North and South America, and parts of Europe (Fig 3). Although Turkey occupies an intermediate, transcontinental position and has a high Human Development Index, it was considered Global South for the purposes of this study. Africa was most prominently represented, with several countries showing high frequencies of studies. The highest number of studies (n = 19) were from Ethiopia, followed by Nigeria (n = 16), Kenya (n = 14), Sudan (n = 14), and Côte d’Ivoire (n = 14), as indicated by the darkest shades on the map in Fig 2. Outside Africa, Brazil (n = 11) and Sri Lanka (n = 8) were the only countries with more than six studies.

Fig 3. Number of skin NTD modelling studies identified by country.

Fig 3

The colour gradient on the map, ranging from (light to dark blue) visually conveys the number of studies per country. Basemap source: Natural Earth, 2024 (http://www.naturalearthdata.com). License: Natural Earth data are in the public domain and freely available for any purpose.

While the vast majority of study countries were in the Global South, more than half of the studies (36 of 68) were led by authors from Global North institutions (Fig 4). Nevertheless, several studies were led by authors from Global South institutions in endemic regions such as Ethiopia (7 studies), Turkey, Sudan, Colombia, and Brazil.

Fig 4. Institutional affiliations of lead authors, by country.

Fig 4

Basemap source: Natural Earth, 2024 (http://www.naturalearthdata.com). License: Natural Earth data are in the public domain and freely available for any purpose.

Modelling approaches used

Of the studies included in the review, 35 were classified as geostatistical models, as they explicitly modelled spatial dependency in some way. These models commonly incorporated spatial correlation structures and environmental factors. Among them, 15 studies used generalized linear mixed models (GLMMs), often within Bayesian or maximum likelihood frameworks (S2 File). A smaller number of geostatistical studies employed interpolation techniques such as inverse distance weighting (IDW; used in five studies), kriging (four), and spline interpolation (three), typically without adjusting for environmental covariates. Ecological models, defined here as those predicting predict disease suitability based on environmental covariates, were used in 33 studies. Among these, generalized linear models (GLMs) were the most widely used method, appearing in 23 studies, followed by maximum entropy (MaxEnt) in 16, and generalized boosted regression trees (BRTs) in nine. Random forest (RF) methods were applied in 11 studies, while Generalized Additive Models (GAMs) were used in ten. Less commonly used ecological approaches included Multivariate Adaptive Regression Splines (MARS) in eight studies and Artificial Neural Networks (ANNs) in six.

Source of epidemiological data

Epidemiological data used in the studies were derived from various resources, reflecting the diverse approaches to gathering health information (Fig 5). The most common source of data was survey data, used in 33 studies (21 spatial and 12 non-spatial). Data originating from passive surveillance (health facility records) were used in 22 studies (14 ecological and eight geostatistical), and case notifications originating from national reporting systems were used in 13 ecological and eight geostatistical studies. Twelve ecological and five geostatistical studies used data captured from literature reviews. The least utilized source was case search, which was reported in only three non-spatial studies. Data sources were multiple for some studies. One study did not report the type of data used for modelling [45].

Fig 5. Source of epidemiological data used for modelling the distribution of skin NTDs.

Fig 5

Inclusion of background or pseudoabsence data

Researchers used background or pseudoabsence points to improve model accuracy and compensate for the lack of reliable true absence data. Of the 68 studies reviewed, 35 used pseudoabsence in place of true absences, and four used both pseudoabsence and true absences, making a total of 40 studies that incorporated pseudoabsence (S2 File). This practice was common in ecological models and some hybrid models that integrated ecological and statistical methods. The most frequent method for generating background data was the random selection of points across the study area, noted in 10 studies. Typically, between 5,000 and 10,000 background points were randomly distributed, sometimes from within buffer zones around presence locations to minimise sampling bias. In five studies, the use of MaxEnt software suggested a default reliance on random background sampling, even when not explicitly stated. In six studies, pseudoabsence data were generated using more systematic or informed approaches. Three studies applied probabilistic methods informed by evidence consensus layers, allowing for targeted selection of pseudoabsence points in regions with lower evidence of disease presence. Two studies used the Surface Range Envelope (SRE) approach to exclude environmentally suitable areas from pseudoabsence generation. One study modelling LF employed expert knowledge to avoid selection of pseudoabsence points from endemic regions or those environmentally suitable for vectors, using land cover classifications and aridity indices. Furthermore, three studies incorporated sampling bias correction techniques, including selection of background points in proximity to occurrence data using a kernel density approach, or using a bias layer representing sampling intensity. Lastly, one geostatistical study introduced zero-prevalence data points in non-endemic areas to account for the high number of zero values and reduce overprediction along the edges of disease-free zones.

Software applied

A wide range of software tools was employed, reflecting diverse and advanced analytical approaches. Forty studies utilised R Statistical Software, leveraging specialized packages for modelling and visualization. Twenty-nine studies used Geographic Information System (GIS) tools, such as ArcGIS and QGIS, GRASS, and Google Earth, which were commonly used for spatial analysis and visualisation, often in combination with R Statistical and MaxEnt-supported species distribution modelling. STATA and SPSS were utilised in three studies, either as a standalone tool or in combination with R. WinBUGS or GeoBUGS were applied in four studies to conduct Bayesian spatial analyses.

Environmental datasets used for modelling

The studies included a variety of environmental datasets that were integrated into models to predict disease distributions (Fig 6). Precipitation was the most commonly used predictor, included in 60 studies. This was followed closely by temperature in 56 studies, highlighting the central role of climatic variables in disease distribution. Topographical factors, including elevation, slope, aspect, and terrain roughness, were used in 50 studies. These were notably applied in studies on CL (n = 17), LF (n = 15), and podoconiosis (n = 7), providing context for understanding the habitats of disease vectors and the spatial distribution of NTDs. For instance, studies in Ethiopia used elevation datasets to estimate podoconiosis cases and assess how altitude influences disease prevalence [46]. Human population density was used in 30 studies, and vegetation indices such as NDVI and Land Surface Temperature (LST) were used in 29 studies. Land use and land cover (LULC) data were used in 28 studies, while datasets representing proximity to water bodies or coastlines were also included in 28 studies. Atmospheric conditions such as aridity and humidity were used in 25 studies, and soil properties were considered in 26 studies, particularly for modelling podoconiosis, where soil composition, structure, and physical characteristics are directly linked to disease risk [47,48].

Fig 6. Environmental Datasets Used for Modelling.

Fig 6

Less commonly used predictors included development indicators, such as night-time light emissivity (16 studies), proxies of exposure (seven studies), livestock density (three studies), and healthcare access and programmatic indicators, each reported in only two studies. The diversity in selected variables reflects a multidimensional approach to understanding disease dynamics across varied geographic, ecological, and socioeconomic contexts. Many of the climatic and environmental datasets, such as rainfall, temperature, humidity, solar radiation, NDVI, LST, and elevation, were obtained from global sources like WorldClim and satellite-based climate reanalysis products.

The process of selecting predictors

In most studies, the process of selecting predictors began with a literature review, drawing on existing research to identify environmental and socio-demographic factors associated with disease transmission and distribution (S2 File). This often served as the foundation for assembling an initial pool of relevant variables. Following this, correlation analysis was commonly used to assess relationships among the selected variables. Highly correlated predictors, such as elevation and temperature variables, are carefully considered, with one often removed to reduce collinearity. In certain cases, variable importance measures were applied, especially when using machine learning models like Random Forests. These models rank variables based on their influence within a model, further refining the selection process by eliminating those with limited impact. Some studies used stepwise selection techniques, including those based on the Akaike Information Criterion (AIC). This iterative approach involves adding and/or removing variables based on their statistical influence, ensuring that only the most significant predictors are retained. Finally, expert judgment complemented the statistical techniques throughout the process. Informed by contextual and field-based knowledge, domain experts validated or retained variables that may not have appeared significant in quantitative analyses but held epidemiological relevance, ensuring the final model reflected the most meaningful drivers of disease distribution.

Sensitivity analysis

Our findings indicated that several sensitivity methods are typically used to assess how robust the model is under varying conditions. One common approach identified was parameter variation, especially in models including MaxEnt and Random Forest. By adjusting key parameters, researchers can test model sensitivity to various inputs and identify which ones are driving the results and which have less influence. Threshold sensitivity in binary classification models was frequently highlighted as a critical consideration. Researchers adjusted decision thresholds and analysis to evaluate how changes influenced the accuracy of predictions. This ensures transparency around the impact of the threshold on predictions.

Methods to evaluate the performance of models

A variety of methods were used to evaluate model performance (S2 File). These include uncertainty quantification (widely used to evaluate geostatistical models), the Receiver Operating Characteristic (ROC) Curve and Area Under the Curve (AUC), cross-validation, goodness-of-fit statistics, classification performance metrics, posterior predictive checking and model convergence, autocorrelation and spatial plots, jackknife tests and variable importance, probability-based evaluation, residual diagnostics, and variograms. A total of seventeen papers mentioned some form of external validation, often referred to as cross-validation, test datasets, out-of-sample predictions, or holding out data for validation. Many studies employed k-fold cross-validation or spatial block cross-validation, where the data are split into subsets to test the model on unseen data, ensuring spatial or temporal independence between training and testing datasets. Additionally, six studies compared model predictions with real-world survey data from locations not included in the model training.

Challenges and limitations of modelling approaches

The review identified several challenges in modelling approaches for predicting skin NTDs. A key issue was the limited availability and inconsistency of epidemiological data, often due to weak health surveillance systems. Additionally, the generalizability of models poses a challenge, as those developed for one region may not apply to others due to varying environmental, social, and demographic factors. Some techniques, such as Bayesian Geostatistical Modelling, require significant computational resources, which can be a barrier in resource-limited settings. Furthermore, the ecological complexity of NTDs, shaped by factors like human behaviour, vector biology, and climate, adds to the modelling difficulties. These challenges underscore the need for improved data collection, the inclusion of diverse covariates, incorporation of techniques to account for variation in surveillance intensity, and robust validation processes to enhance predictive accuracy and relevance across different contexts.

Risk of bias assessment

Across the 68 studies assessed, 23 (35%) were rated low risk of bias, 26 (38%) moderate, and 19 (27%) high (S3 File). While most studies clearly defined study areas and applied appropriate analyses, weaknesses were common in participant representativeness, sampling bias, and the handling of spatial autocorrelation within ENMs. Geostatistical approaches tended to achieve lower risk ratings (53% rated as low and 15% rated as high), whereas ecological niche modelling studies were more often classified as high risk (12% rated as low and 42% rated as high).

Discussion

This systematic literature review aimed to examine and synthesise modelling approaches used to predict the distribution of skin NTDs, with a focus on identifying predominant methods, evaluating their applications, and highlighting research gaps. A total of 68 studies were included.

Studies were geographically diverse, with a large proportion of studies conducted in Africa. Lead author institutions were almost evenly distributed between the Global North (36 studies) and the Global South (32 studies). Although the UK and USA had the highest number of studies by lead author, endemic countries such as Ethiopia, Turkey, Sudan, and Brazil are leading their own modelling efforts.

Most studies focused on vector-borne diseases (VBDs), such as CL, LF, and onchocerciasis. The review revealed significant diversity in model types, with both geostatistical and ecological models used extensively. The studies used different types of epidemiological data, most commonly survey and passive surveillance data, and the selection of covariates varied depending on the disease, with climate, elevation, land cover, and soil type being commonly applied predictors.

The key finding of this review is the dominant use of geostatistical models in the prediction of skin NTD distributions, especially GLMMs for capturing spatial patterns. These models, including Bayesian and generalised linear mixed models, explicitly incorporate spatial dependency and provide more robust predictions for diseases with continuous prevalence outcomes. This is consistent with approaches used in other NTDs, such as schistosomiasis and STHs, and reflects an increasing recognition of the importance of spatial autocorrelation in disease mapping [49]. These studies most often used high-quality survey data as a primary data source, indicating a preference for higher-quality, structured data in spatial modelling efforts.

In addition, ecological models continued to be used, especially in studies relying on presence-only data from health facility reports, case notifications, or extracted from the literature. These models do not account for spatial structure but are widely used due to potential application without true absence data. Ecological models addressed data limitations by incorporating pseudoabsence points, often using random or evidence-informed sampling. While flexible, this can limit reliability, reduce accuracy, and even exacerbate biases. The majority of ecological models in this review used spatially random pseudoabsence points, which can mis represent areas which are suitable for a disease but in which it has not yet emerged, or has not been detected. Depending on the context and study area, alternative approaches may be more appropriate. The use of evidence consensus layers to select pseudoabsences in areas less likely to be endemic can reduce the risk of pseudoabsences being selected from within suitable areas [40]. The surface range envelope approach, which restricts pseudoabsences to areas that are environmentally distinct from occurrence locations, can also help to reduce this effect. However, if sampling was targeted (intentionally or unintentionally) to locations with particular environmental characteristics, this can exacerbate the impact of selection bias [50]. Studies included in this review used environmental and climatic variables, especially precipitation and temperature, which were the most used predictors across the studies included. These environmental factors are known to significantly influence the distribution of vector-borne and environmentally mediated diseases. Other commonly used predictors included elevation, land cover, vegetation indices, and soil characteristics, particularly in podoconiosis models [51]. The selection process for predictors was typically informed by prior literature, expert judgement, and correlation testing.

Although in risk of bias assessment about one-third of the studies were classified as low risk, the majority were rated as moderate or high risk, reflecting recurring weaknesses in sampling, spatial autocorrelation, and reliance on presence‑only data, these limitations undermine confidence in outputs and their policy relevance. In contrast, studies applying rigorous geostatistical methods showed stronger quality, underscoring the importance of standardized methodologies and transparent reporting practices.

The models reviewed have important practical applications. These models can help target interventions by identifying high-risk areas, allowing health authorities to direct resources efficiently. For example, in Ghana, spatial models predicted schistosomiasis prevalence [52], allowing for targeted MDA campaigns. This was achieved through Model-Based Geostatistics (MBG), integrating environmental factors and parasitological data, demonstrating how models can support effective resource allocation for NTD control [53]. To support the uptake of models for public health planning, authors should engage with decision makers to identify the most useful presentation of estimates. For example, summaries such as population living in suitable areas or number of people infected are likely to be more useful for resource allocation than continuous surfaces at national or continental level. For increased interpretability of continuous outputs, authors could present these at lower levels in supplementary material, or even better, as an interactive application allowing users to zoom in on locations of interest [54]. Prediction outputs for different skin NTDs could also be overlaid to show overlapping risk areas, identifying targets for integrated interventions, as promoted by the WHO skin NTD strategy2. However, this may be limited by the diversity of approaches used for modelling different diseases. End-users’ confidence in model outputs may be limited by their understanding of the methodologies, trust in the data used, and prediction accuracy. Increased transparency in the reporting of methods and results would go some way towards addressing this. We identified studies which did not report key components including the source of epidemiological data, the approach to pseudoabsence generation, the spatial resolution, and prediction uncertainty, and only seven of 68 publications made their model code available. Adoption of minimum reporting standards checklists for ecological niche models and geostatistical models would enhance transparency and trust in outputs. Despite promising developments, there are multiple challenges in developing and applying models for skin NTDs. A key challenge lies in the limited and often inconsistent epidemiological data across regions, largely resulting from underreporting and inadequate surveillance systems. The lack of true absence data and the reliance on pseudoabsence points introduce additional uncertainty into models [55]. Furthermore, the complex interplay of environmental, biological, and socio-economic drivers of skin NTDs makes them challenging to model accurately. Models developed using data from one region may lack generalizability to others due to environmental and socio-demographic differences. Key strengths of this review include a comprehensive search strategy and a double-review process for screening and data extraction, which adds rigor and reduces bias. However, it also has limitations, such as the exclusion of grey literature and potential publication bias. The heterogeneity of included studies, in terms of model types, data sources, and outcomes, makes it difficult to perform direct comparisons or quantitative synthesis.

Conclusions

Modelling of skin NTDs is an emerging and growing field with substantial potential for supporting control and elimination strategies. However, the wide variation in methodologies and input data quality suggests a lack of cohesion and best practice across studies. Although these models can yield highly informative outputs, their utility hinges on the credibility and transparency of the modelling methodologies employed. For future research, there is a need to develop models that incorporate more comprehensive environmental, biological, and socio-economic covariates, as these are critical to understanding the complex transmission dynamics of skin NTDs. Increasing access to model codes and encouraging the use of more advanced modelling techniques, such as Bayesian Geostatistical Models, could also lead to improvements in predictive accuracy. Collaborative efforts between researchers, governments, and public health organizations will be essential to overcome data limitations and extend the reach of these modelling tools into endemic regions. With improved transparency and collaboration, predictive models can meaningfully contribute to WHO’s 2030 NTD elimination targets. Strengthening modelling capacity in endemic regions through equitable collaborations and sustained investment will be critical to achieving scientific equity and ensuring that predictive models directly inform national disease control programs.

Registration and protocol

The protocol for this systematic review was registered with the Open Science Framework (OSF) (registration https://doi.org/10.17605/OSF.IO/H6B5N). The full protocol is publicly accessible at the registration link.

Supporting information

S1 File. Master list of all studies identified (n = 818) after duplicate removal.

(XLSX)

pntd.0013662.s001.xlsx (686.9KB, xlsx)
S2 File. Supplementary Table.

Extracted data for the 68 included studies.

(DOCX)

pntd.0013662.s002.docx (141.7KB, docx)
S3 File. Supplementary Table.

Risk of bias and quality assessments for the 68 included studies.

(DOCX)

pntd.0013662.s003.docx (44.6KB, docx)
S4 File. Supplementary PRISMA 2020 Checklist (PRISMA 2020 checklist SRV RA025.docx).

Completed PRISMA 2020 checklist indicating where each reporting item is addressed in the manuscript.

(DOCX)

pntd.0013662.s004.docx (274.6KB, docx)

Data Availability

All data underlying the findings are fully available within the manuscript and its Supporting Information files. Extracted data from included studies and analysis scripts are provided as supplementary materials.

Funding Statement

This research is funded by the National Institute for Health and Care Research (NIHR) (16/13629 to GD) Global Health Research Unit Programme. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Davey G, Tekola F, Newport MJ. Podoconiosis: non-infectious geochemical elephantiasis. Trans R Soc Trop Med Hyg. 2007;101(12):1175–80. doi: 10.1016/j.trstmh.2007.08.013 [DOI] [PubMed] [Google Scholar]
  • 2.Yotsu RR, Fuller LC, Murdoch ME, Revankar C, Barogui YT, Pemmaraju VRR, et al. World Health Organization strategic framework for integrated control and management of skin-related neglected tropical diseases: what does this mean for dermatologists?. Br J Dermatol. 2023;188(2):157–9. doi: 10.1093/bjd/ljac031 [DOI] [PubMed] [Google Scholar]
  • 3.Smith CD, Mennis J. Incorporating Geographic Information Science and Technology in Response to the COVID-19 Pandemic. Prev Chronic Dis. 2020;17:E58. doi: 10.5888/pcd17.200246 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.World Health Organization. Ending the neglect to attain the sustainable development goals: a strategic framework for integrated control and management of skin-related neglected tropical diseases. Geneva: World Health Organization. 2022. https://www.who.int/publications-detail-redirect/9789240051423 [Google Scholar]
  • 5.Mitjà O, Marks M, Bertran L, Kollie K, Argaw D, Fahal AH, et al. Integrated Control and Management of Neglected Tropical Skin Diseases. PLoS Negl Trop Dis. 2017;11(1):e0005136. doi: 10.1371/journal.pntd.0005136 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.World Health Organization. Global report on neglected tropical diseases 2023. Geneva: World Health Organization. 2023. https://www.who.int/teams/control-of-neglected-tropical-diseases/global-report-on-neglected-tropical-diseases-2023 [Google Scholar]
  • 7.Simpson H, Quao B, Van Der Grinten E. Routine surveillance data as a resource for planning integration of NTD case management. Lepr Rev. 2018;89(3):178–96. doi: 10.47276/lr.89.3.178 [DOI] [Google Scholar]
  • 8.World Health Organization. Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030. Geneva: World Health Organization. 2021. https://www.who.int/publications-detail-redirect/9789240010352 [Google Scholar]
  • 9.Gage KL, Burkot TR, Eisen RJ, Hayes EB. Climate and vectorborne diseases. Am J Prev Med. 2008;35(5):436–50. doi: 10.1016/j.amepre.2008.08.030 [DOI] [PubMed] [Google Scholar]
  • 10.Pluschke G, Röltgen K. Epidemiology and disease burden of Buruli ulcer: a review. Res Rep Trop Med. 2015;2015:59. doi: 10.2147/RRTM.S62026 [DOI] [Google Scholar]
  • 11.Marks M, Mitjà O, Vestergaard LS, Pillay A, Knauf S, Chen C-Y, et al. Challenges and key research questions for yaws eradication. Lancet Infect Dis. 2015;15(10):1220–5. doi: 10.1016/S1473-3099(15)00136-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Browne E, Driessen MM, Cross PC, Escobar LE, Foley J, López-Olvera JR, et al. Sustaining Transmission in Different Host Species: The Emblematic Case ofSarcoptes scabiei. BioScience. 2021;72(2):166–76. doi: 10.1093/biosci/biab106 [DOI] [Google Scholar]
  • 13.Cosma C, Maia C, Khan N, Infantino M, Del Riccio M. Leishmaniasis in Humans and Animals: A One Health Approach for Surveillance, Prevention and Control in a Changing World. Trop Med Infect Dis. 2024;9(11):258. doi: 10.3390/tropicalmed9110258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.World Health Organization. Data quality assessment for neglected tropical diseases: facilitator’s manual. Geneva: World Health Organization. 2018. https://apps.who.int/iris/handle/10665/259972 [Google Scholar]
  • 15.Johnson RC, Phanzu DM, Guédénon A, Portaels F. Clinical Features of Buruli Ulcer. Leprosy and Buruli Ulcer: A Practical Guide. Springer International Publishing. 2022. 455–63. doi: 10.1007/978-3-030-89704-8_42 [DOI] [Google Scholar]
  • 16.World Health Organization. Control of neglected tropical diseases: podoconiosis (endemic non‑filarial elephantiasis). Geneva: World Health Organization. 2024. https://www.who.int/teams/control-of-neglected-tropical-diseases/lymphatic-filariasis/podoconiosis-endemic-non-filarial-elephantiasis [Google Scholar]
  • 17.Simpson H, Mengiste A, Mbonigaba JB, Kollie K, Nganda M, Dean L, et al. Research priorities to support the development of integrated national strategies to control skin-neglected tropical diseases. Trans R Soc Trop Med Hyg. 2023;117(2):132–8. doi: 10.1093/trstmh/trac086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–7. doi: 10.1038/nature12060 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Peterson A, Soberón J. Species distribution modeling and ecological niche modeling: getting the concepts right. Nat E Conserv. 2012;10:1–6. doi: 10.4322/natcon.2012.019 [DOI] [Google Scholar]
  • 20.Farashi A, Alizadeh-Noughani M. Basic Introduction to Species Distribution Modelling. Ecosystem and Species Habitat Modeling for Conservation and Restoration. Springer Nature Singapore. 2023. 21–40. doi: 10.1007/978-981-99-0131-9_2 [DOI] [Google Scholar]
  • 21.Martínez-Minaya J, Cameletti M, Conesa D, Pennino MG. Species distribution modeling: a statistical review with focus in spatio-temporal issues. Stoch Environ Res Risk Assess. 2018;32(11):3227–44. doi: 10.1007/s00477-018-1548-7 [DOI] [Google Scholar]
  • 22.Johnson EE, Escobar LE, Zambrana-Torrelio C. An Ecological Framework for Modeling the Geography of Disease Transmission. Trends Ecol Evol. 2019;34(7):655–68. doi: 10.1016/j.tree.2019.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Melo-Merino SM, Reyes-Bonilla H, Lira-Noriega A. Ecological niche models and species distribution models in marine environments: A literature review and spatial analysis of evidence. Ecol Model. 2020;415:108837. doi: 10.1016/j.ecolmodel.2019.108837 [DOI] [Google Scholar]
  • 24.Thomson MC, Connor SJ, D’Alessandro U, Rowlingson B, Diggle P, Cresswell M, et al. Predicting malaria infection in Gambian children from satellite data and bed net use surveys: the importance of spatial correlation in the interpretation of results. Am J Trop Med Hyg. 1999;61(1):2–8. doi: 10.4269/ajtmh.1999.61.2 [DOI] [PubMed] [Google Scholar]
  • 25.Giorgi E, Diggle PJ, Snow RW, Noor AM. Geostatistical Methods for Disease Mapping and Visualisation Using Data from Spatio-temporally Referenced Prevalence Surveys. Int Stat Rev. 2018;86(3):571–97. doi: 10.1111/insr.12268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Johnson O, Fronterre C, Amoah B, Montresor A, Giorgi E, Midzi N, et al. Model-Based Geostatistical Methods Enable Efficient Design and Analysis of Prevalence Surveys for Soil-Transmitted Helminth Infection and Other Neglected Tropical Diseases. Clin Infect Dis. 2021;72(Suppl 3):S172–9. doi: 10.1093/cid/ciab192 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Fronterre C, Amoah B, Giorgi E, Stanton MC, Diggle PJ. Design and Analysis of Elimination Surveys for Neglected Tropical Diseases. J Infect Dis. 2020;221(Suppl 5):S554–60. doi: 10.1093/infdis/jiz554 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ault SK, Nicholls RS, Saboya MI. The Pan American Health Organization’s role and perspectives on the mapping and modeling of the neglected tropical diseases in Latin America and the Caribbean: an overview. Geospat Health. 2012;6(3):S7-9. doi: 10.4081/gh.2012.116 [DOI] [PubMed] [Google Scholar]
  • 29.Hamm NAS, Soares Magalhães RJ, Clements ACA. Earth Observation, Spatial Data Quality, and Neglected Tropical Diseases. PLoS Negl Trop Dis. 2015;9(12):e0004164. doi: 10.1371/journal.pntd.0004164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hengl T, Sierdsema H, Radović A, Dilo A. Spatial prediction of species’ distributions from occurrence-only records: combining point pattern analysis, ENFA and regression-kriging. Ecol Model. 2009;220(24):3499–511. doi: 10.1016/j.ecolmodel.2009.06.038 [DOI] [Google Scholar]
  • 31.Rayyan, Intelligent Systematic Review. https://rayyan.ai/news 2025 August 7.
  • 32.Feng X, Park DS, Walker C, Peterson AT, Merow C, Papeş M. A checklist for maximizing reproducibility of ecological niche models. Nat Ecol Evol. 2019;3(10):1382–95. doi: 10.1038/s41559-019-0972-5 [DOI] [PubMed] [Google Scholar]
  • 33.The R Project for Statistical Computing. https://www.r-project.org/ 2024 December 10.
  • 34.Hassan R, Simpson H, Cano J, Bakhiet S, Ganawa E, Argaw D, et al. Modelling the spatial distribution of mycetoma in Sudan. Trans R Soc Trop Med Hyg. 2021;115(10):1144–52. doi: 10.1093/trstmh/trab076 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Samy AM, van de Sande WWJ, Fahal AH, Peterson AT. Mapping the potential risk of mycetoma infection in Sudan and South Sudan using ecological niche modeling. PLoS Negl Trop Dis. 2014;8(10):e3250. doi: 10.1371/journal.pntd.0003250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hassan R, Cano J, Fronterre C, Bakhiet S, Fahal A, Deribe K, et al. Estimating the burden of mycetoma in Sudan for the period 1991-2018 using a model-based geostatistical approach. PLoS Negl Trop Dis. 2022;16(10):e0010795. doi: 10.1371/journal.pntd.0010795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Deka MA, Heukelbach J. Distribution of tungiasis in latin America: Identification of areas for potential disease transmission using an ecological niche model. Lancet Reg Health Am. 2021;5:100080. doi: 10.1016/j.lana.2021.100080 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hyuga A, Larson PS, Ndemwa M, Muuo SW, Changoma M, Karama M, et al. Environmental and Household-Based Spatial Risks for Tungiasis in an Endemic Area of Coastal Kenya. Trop Med Infect Dis. 2021;7(1):2. doi: 10.3390/tropicalmed7010002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Deka MA. Mapping the Geographic Distribution of Tungiasis in Sub-Saharan Africa. Trop Med Infect Dis. 2020;5(3):122. doi: 10.3390/tropicalmed5030122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Simpson H, Tabah EN, Phillips RO, Frimpong M, Maman I, Ampadu E, et al. Mapping suitability for Buruli ulcer at fine spatial scales across Africa: A modelling study. PLoS Negl Trop Dis. 2021;15(3):e0009157. doi: 10.1371/journal.pntd.0009157 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Campbell LP, Finley AO, Benbow ME. Spatial analysis of anthropogenic landscape disturbance and Buruli ulcer disease in Benin. PLoS Negl Trop Dis. 2015;9(10):e0004123. doi: 10.1371/journal.pntd.0004123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Duarte-Cunha M, Almeida Asd, Cunha GMd, Souza-Santos R. Geographic weighted regression: applicability to epidemiological studies of leprosy. Rev Soc Bras Med Trop. 2016;49(1):74–82. doi: 10.1590/0037-8682-0307-2015 [DOI] [PubMed] [Google Scholar]
  • 43.Duarte-Cunha M, Marcelo da Cunha G, Souza-Santos R. Geographical heterogeneity in the analysis of factors associated with leprosy in an endemic area of Brazil: are we eliminating the disease?. BMC Infect Dis. 2015;15:196. doi: 10.1186/s12879-015-0924-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Eneanya OA, Delea MG, Cano J, Tchindebet PO, Richards RL, Zhao Y, et al. Predicting the Environmental Suitability and Identifying Climate and Sociodemographic Correlates of Guinea Worm (Dracunculus medinensis) in Chad. Am J Trop Med Hyg. 2024;111(3_Suppl):26–35. doi: 10.4269/ajtmh.23-0681 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Rachmawati RN, Rahman JY, Pusponegoro NH. Bayesian spatial hierarchical mixture models for excess zeros data: review and application to female lymphatic filariasis cases. Commun Math Biol Neurosci. 2024;2024(0):Article ID 20. doi: 10.28919/cmbn/8428 [DOI] [Google Scholar]
  • 46.Deribe K, Cano J, Giorgi E, Pigott DM, Golding N, Pullan RL, et al. Estimating the number of cases of podoconiosis in Ethiopia using geostatistical methods. Wellcome Open Res. 2017;2:78. doi: 10.12688/wellcomeopenres.12483.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Deribe K, Sultani HM, Okoyo C, Omondi WP, Ngere I, Newport MJ, et al. Geostatistical modelling of the distribution, risk and burden of podoconiosis in Kenya. Trans R Soc Trop Med Hyg. 2023;117(2):72–82. doi: 10.1093/trstmh/trac092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Eneanya OA, Cano J, Dorigatti I, Anagbogu I, Okoronkwo C, Garske T, et al. Environmental suitability for lymphatic filariasis in Nigeria. Parasit Vectors. 2018;11(1):513. doi: 10.1186/s13071-018-3097-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Clements ACA, Deville M-A, Ndayishimiye O, Brooker S, Fenwick A. Spatial co-distribution of neglected tropical diseases in the east African great lakes region: revisiting the justification for integrated control. Trop Med Int Health. 2010;15(2):198–207. doi: 10.1111/j.1365-3156.2009.02440.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Warton DI, Renner IW, Ramp D. Model-based control of observer bias for the analysis of presence-only data in ecology. PLoS One. 2013;8(11):e79168. doi: 10.1371/journal.pone.0079168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Deribe K, Mbituyumuremyi A, Cano J, Jean Bosco M, Giorgi E, Ruberanziza E, et al. Geographical distribution and prevalence of podoconiosis in Rwanda: a cross-sectional country-wide survey. Lancet Glob Health. 2019;7(5):e671–80. doi: 10.1016/S2214-109X(19)30072-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Barro AS, Oyana TJ. Predictive and epidemiologic modeling of the spatial risk of human onchocerciasis using biophysical factors: a case study of Ghana and Burundi. Spat Spatiotemporal Epidemiol. 2012;3(4):273–85. doi: 10.1016/j.sste.2012.08.001 [DOI] [PubMed] [Google Scholar]
  • 53.Kabore A, Biritwum N-K, Downs PW, Soares Magalhaes RJ, Zhang Y, Ottesen EA. Predictive vs. empiric assessment of schistosomiasis: implications for treatment projections in Ghana. PLoS Negl Trop Dis. 2013;7(3):e2051. doi: 10.1371/journal.pntd.0002051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Awine T, Malm K, Bart-Plange C, Silal SP. Towards malaria control and elimination in Ghana: challenges and decision making tools to guide planning. Glob Health Action. 2017;10(1):1381471. doi: 10.1080/16549716.2017.1381471 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Hassan R, Simpson H, Cano J, Bakhiet S, Ganawa E, Argaw D, et al. Modelling the spatial distribution of mycetoma in Sudan. Trans R Soc Trop Med Hyg. 2021;115(10):1144–52. doi: 10.1093/trstmh/trab076 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013662.r001

Decision Letter 0

Paul Mireji

4 Mar 2026

-->PNTD-D-25-01471-->-->Modelling Approaches for Predicting the Distribution of skin NTDs: A Systematic Review-->-->PLOS Neglected Tropical Diseases-->--> -->-->Dear Dr. A.Bushara,-->--> -->-->Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.-->--> -->-->Please submit your revised manuscript by May 03 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.-->--> -->-->Please include the following items when submitting your revised manuscript:-->-->* A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.-->-->* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.-->-->* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.-->--> -->-->If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.-->--> -->-->We look forward to receiving your revised manuscript.-->--> -->-->Kind regards,-->--> -->-->Paul O. Mireji, PhD-->-->Section Editor-->-->PLOS Neglected Tropical Diseases-->--> -->-->Paul Mireji-->-->Section Editor-->-->PLOS Neglected Tropical Diseases-->-->

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

-->--> -->-->Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.-->--> -->-->

1) Please ensure that the CRediT author contributions listed for every co-author are completed accurately and in full.

At this stage, the following Authors/Authors require contributions: Mesoud A.Bushara, Mesoud A. Bushara, Rowa Hassan, Rana Ahmed, Jorge Cano, Gail Davey, Eltayeb Ganawa, and Hope Simpson. Please ensure that the full contributions of each author are acknowledged in the "Add/Edit/Remove Authors" section of our submission form.

The list of CRediT author contributions may be found here: https://journals.plos.org/plosntds/s/authorship#loc-author-contributions

2) We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type u2018LaTeX Source Fileu2019 and leave your .pdf version as the item type u2018Manuscriptu2019.

3) We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list.

4) Some material included in your submission may be copyrighted. According to PLOSu2019s copyright policy, authors who use figures or other material (e.g., graphics, clipart, maps) from another author or copyright holder must demonstrate or obtain permission to publish this material under the Creative Commons Attribution 4.0 International (CC BY 4.0) License used by PLOS journals. Please closely review the details of PLOSu2019s copyright requirements here: PLOS Licenses and Copyright. If you need to request permissions from a copyright holder, you may use PLOS's Copyright Content Permission form.

Please respond directly to this email and provide any known details concerning your material's license terms and permissions required for reuse, even if you have not yet obtained copyright permissions or are unsure of your material's copyright compatibility. Once you have responded and addressed all other outstanding technical requirements, you may resubmit your manuscript within Editorial Manager.

Potential Copyright Issues:

i) Figure 3. Please (a) provide a direct link to the base layer of the map (i.e., the country or region border shape) and ensure this is also included in the figure legend; and (b) provide a link to the terms of use / license information for the base layer image or shapefile. We cannot publish proprietary or copyrighted maps (e.g. Google Maps, Mapquest) and the terms of use for your map base layer must be compatible with our CC BY 4.0 license.

Note: if you created the map in a software program like R or ArcGIS, please locate and indicate the source of the basemap shapefile onto which data has been plotted.

If your map was obtained from a copyrighted source please amend the figure so that the base map used is from an openly available source. Alternatively, please provide explicit written permission from the copyright holder granting you the right to publish the material under our CC BY 4.0 license.

If you are unsure whether you can use a map or not, please do reach out and we will be able to help you. The following websites are good examples of where you can source open access or public domain maps:

* U.S. Geological Survey (USGS) - All maps are in the public domain. (http://www.usgs.gov)

* PlaniGlobe - All maps are published under a Creative Commons license so please cite u201cPlaniGlobe, http://www.planiglobe.com, CC BY 2.0u201d in the image credit after the caption. (http://www.planiglobe.com/?lang=enl)

* Natural Earth - All maps are public domain. (http://www.naturalearthdata.com/about/terms-of-use/).

5) Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published.

1) State the initials, alongside each funding source, of each author to receive each grant. For example: "This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM)."

2) State what role the funders took in the study. If the funders had no role in your study, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

3) If any authors received a salary from any of your funders, please state which authors and which funders..

If you did not receive any funding for this study, please simply state: u201cThe authors received no specific funding for this work.u201d

6) As required by our policy on Data Availability, please ensure your manuscript or supplementary information includes the following:

- A numbered table of all studies identified in the literature search, including those that were excluded from the analyses.

- For every excluded study, the table should list the reason(s) for exclusion.

- If any of the included studies are unpublished, include a link (URL) to the primary source or detailed information about how the content can be accessed.

- A table of all data extracted from the primary research sources for the systematic review and/or meta-analysis. The table must include the following information for each study:

- Name of data extractors and date of data extraction

- Confirmation that the study was eligible to be included in the review.

- All data extracted from each study for the reported systematic review and/or meta-analysis that would be needed to replicate your analyses.

- If data or supporting information were obtained from another source (e.g. correspondence with the author of the original research article), please provide the source of data and dates on which the data/information were obtained by your research group.

- If applicable for your analysis, a table showing the completed risk of bias and quality/certainty assessments for each study or outcome.  Please ensure this is provided for each domain or parameter assessed. For example, if you used the Cochrane risk-of-bias tool for randomized trials, provide answers to each of the signalling questions for each study. If you used GRADE to assess certainty of evidence, provide judgements about each of the quality of evidence factor. This should be provided for each outcome.

- An explanation of how missing data were handled.

This information can be included in the main text, supplementary information, or relevant data repository. Please note that providing these underlying data is a requirement for publication in this journal, and if these data are not provided your manuscript might be rejected.

-->-->Reviewers' comments:-->--> -->-->Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: Yes to all

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: yes to all, but see comments to authors

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: yes to all

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: This is a very well written article. I really have only minor comments which are mostly optional.

Line 82- I think I would scabies has been reported to be seasonal in some settings but not others (for exmaple there doesnt appear to be any meaningful seasonal influence in the Pacific).

Geostatical models were used in 34 and ecologolical in 33. What was used in the other 2 models?

Did you look to see where the modelling work was being done? i.e is this people from the global north doing all the modelling?

Reviewer #2: This review examines how predictive modelling has been applied to map the distribution of skin NTDs, analyses the types of approaches used and their suitability for informing public health surveillance and control strategies. It also analyse existing evidence gaps and opportunities to strengthen their contribution to planning and decision-making at the programme level.

The methodology used is sound both for the study design and its registration, following good practices for systematic reviews. Description of results and discussion is easy to follow and presented in a manner that can contribute to improve the application of modelling.

I would like to share just a few minor comments aimed at improving the accessibility of this work for readers who may be less familiar with modelling approaches, and for its clarity:

1. A table describing the main characteristics/differences of the ecological models ENM, SDM and risk mappingn would be useful.

2. Explain why the search was restricted to year 200 and onwards.

3. Languages included, explain why English, French, Portuguese, Spanish, and Turkish.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

-->--> -->-->Figure resubmission:-->--> -->-->-->While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.-->-->

After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.-->-->--> -->-->Reproducibility:-->--> -->-->To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols-->

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013662.r003

Decision Letter 1

Paul Mireji

22 Apr 2026

Dear Mr. A.Bushara,

We are pleased to inform you that your manuscript 'Modelling Approaches for Predicting the Distribution of skin NTDs: A Systematic Review' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Paul O. Mireji, PhD

Section Editor

PLOS Neglected Tropical Diseases

Paul Mireji

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

***********************************************************

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 16.0px; font: 14.0px Arial; color: #323333; -webkit-text-stroke: #323333}span.s1 {font-kerning: none

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: I am satisfied the comments have been addressed.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013662.r004

Acceptance letter

Paul Mireji

Dear Mr. A.Bushara,

We are delighted to inform you that your manuscript, "Modelling Approaches for Predicting the Distribution of skin NTDs: A Systematic Review," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Master list of all studies identified (n = 818) after duplicate removal.

    (XLSX)

    pntd.0013662.s001.xlsx (686.9KB, xlsx)
    S2 File. Supplementary Table.

    Extracted data for the 68 included studies.

    (DOCX)

    pntd.0013662.s002.docx (141.7KB, docx)
    S3 File. Supplementary Table.

    Risk of bias and quality assessments for the 68 included studies.

    (DOCX)

    pntd.0013662.s003.docx (44.6KB, docx)
    S4 File. Supplementary PRISMA 2020 Checklist (PRISMA 2020 checklist SRV RA025.docx).

    Completed PRISMA 2020 checklist indicating where each reporting item is addressed in the manuscript.

    (DOCX)

    pntd.0013662.s004.docx (274.6KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pntd.0013662.s006.docx (108.2KB, docx)

    Data Availability Statement

    All data underlying the findings are fully available within the manuscript and its Supporting Information files. Extracted data from included studies and analysis scripts are provided as supplementary materials.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES